Capricor Therapeutics (CAPR) stock, explained like you're 5

Is Capricor Therapeutics a small, medium or large cap company?

No. Capricor Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 455 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Capricor Therapeutics makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves CAPR stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• CAPR Stock Climbs On FDA’s Three Month Deramiocel Extension HC Wainwright Sticks To Neutral, Flags High Rejection Risk (Stocktwits)
• Voting power over 1.67M Capricor (CAPR) shares is shared by three reporting parties. (Stock Titan)
• What's Going On With Capricor Therapeutics Stock Monday? (Benzinga)
• CAPR Oct 2026 7.000 call (CAPR261016C00007000) interactive stock chart (Yahoo Finance UK)
• Capricor Therapeutics, Inc. (CAPR) Discusses HOPE 3 Open Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy Slideshow (NASDAQ:CAPR) 2026 10 13 (Seeking Alpha)

Key terms to know before you follow CAPR

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility